A novel function for transforming growth factor-beta1: upregulation of the expression and the IgE-independent extracellular release of a mucosal mast cell granule-specific beta-chymase, mouse mast cell protease-1.

Abstract:

:Intestinal mucosal mast cells (IMMC) express granule neutral proteases that are regulated by T-cell-derived cytokines, including interleukin-3 (IL-3) and IL-9, and by stem cell factor (SCF). The IMMC-specific chymase, mouse mast cell protease-1 (mMCP-1), is released in substantial quantities into the blood stream during gastrointestinal allergic responses. We used cultured bone marrow-derived mast cells (mBMMC) to identify cytokines that regulate the expression and extracellular release of mMCP-1. When grown in IL-3-rich WEHI (15% vol/vol) and 50 ng/mL recombinant rat SCF (rrSCF) bone marrow cells supplemented with IL-9 (5 ng/mL) differentiated into mBMMC that expressed a maximum of less than 250 ng mMCP-1/10(6) cells and 189 ng mMCP-1/mL of culture supernatant. Supplementation of the same three cytokines with transforming growth factor-beta1 (TGF-beta1; 1 ng/mL) resulted in substantially enhanced expression (6 micrograms/10(6) mBMMC) and extracellular release (2 micrograms/mL of culture supernatant) of mMCP-1. The response to TGF-beta1 was dose-dependent, with maximal effect at 1 ng/mL, and was associated with immunohistochemical and ultrastructural changes in the secretory granules. IL-9-induced expression of mMCP-1 may be due to endogenously expressed TGF-beta1, because it was blocked by anti-TGF-beta antibodies. In conclusion, the expression and extracellular release of the IMMC-specific chymase, mMCP-1, is strictly regulated by TGF-beta1.

journal_name

Blood

journal_title

Blood

authors

Miller HR,Wright SH,Knight PA,Thornton EM

subject

Has Abstract

pub_date

1999-05-15 00:00:00

pages

3473-86

issue

10

eissn

0006-4971

issn

1528-0020

journal_volume

93

pub_type

杂志文章

相关文献

BLOOD文献大全
  • How I manage ibrutinib-refractory chronic lymphocytic leukemia.

    abstract::The introduction of the Bruton tyrosine kinase (BTK) inhibitor ibrutinib has dramatically changed the management of chronic lymphocytic leukemia (CLL). Although responses have been durable in the majority of patients, relapses do occur, especially in the high-risk patient population. Most relapses occur as the result ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2016-09-693598

    authors: Woyach JA

    更新日期:2017-03-09 00:00:00

  • Perturbed hematopoiesis in mice lacking ATMIN.

    abstract::The ataxia telangiectasia mutated (ATM)-interacting protein ATMIN mediates noncanonical ATM signaling in response to oxidative and replicative stress conditions. Like ATM, ATMIN can function as a tumor suppressor in the hematopoietic system: deletion of Atmin under the control of CD19-Cre results in B-cell lymphomas i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-09-672980

    authors: Anjos-Afonso F,Loizou JI,Bradburn A,Kanu N,Purewal S,Da Costa C,Bonnet D,Behrens A

    更新日期:2016-10-20 00:00:00

  • One siRNA pool targeting the λ constant region stops λ light-chain production and causes terminal endoplasmic reticulum stress.

    abstract::In systemic light-chain amyloidosis, λ light chains produced by clonal plasma cells cause organ damage and early death. In pursuit of novel therapy, we developed 1 pool of short interfering RNA (siRNA) targeting the constant region of λ light chains that substantially and promptly reduces λ-light-chain production and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-10-535187

    authors: Zhou P,Ma X,Iyer L,Chaulagain C,Comenzo RL

    更新日期:2014-05-29 00:00:00

  • The role of phosphatidylinositol 3-kinase-δ in the immunomodulatory effects of lenalidomide in chronic lymphocytic leukemia.

    abstract::In patients with chronic lymphocytic leukemia (CLL), lenalidomide can promote humoral immune responses but also induces a distinct disease-specific toxicity of tumor flare and cytokine release. These CLL-specific events result from increased expression of costimulatory molecules on B cells. Here we demonstrate that le...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-11-315705

    authors: Herman SE,Lapalombella R,Gordon AL,Ramanunni A,Blum KA,Jones J,Zhang X,Lannutti BJ,Puri KD,Muthusamy N,Byrd JC,Johnson AJ

    更新日期:2011-04-21 00:00:00

  • Genetic elimination of prothrombin in adult mice is not compatible with survival and results in spontaneous hemorrhagic events in both heart and brain.

    abstract::Mice carrying a conditional prothrombin knockout allele (fII(lox)) were established to develop an experimental setting for exploring the importance of thrombin in the maintenance of vascular integrity, the inflammatory response, and disease processes in adult animals. In the absence of Cre-mediated recombination, homo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-07-169003

    authors: Mullins ES,Kombrinck KW,Talmage KE,Shaw MA,Witte DP,Ullman JM,Degen SJ,Sun W,Flick MJ,Degen JL

    更新日期:2009-01-15 00:00:00

  • Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.

    abstract::Type 3 von Willebrand disease (VWD) is a severe hemorrhagic defect in humans. We now identify the homozygous mutation in the Chapel Hill strain of canine type 3 VWD that results in premature termination of von Willebrand factor (VWF) protein synthesis. We cultured endothelium from VWD and normal dogs to study intracel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0464

    authors: Haberichter SL,Merricks EP,Fahs SA,Christopherson PA,Nichols TC,Montgomery RR

    更新日期:2005-01-01 00:00:00

  • A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma.

    abstract::Infections during granulocytopenia are major complications of autologous bone marrow transplantation (ABMT). Since recombinant human granulocyte-macrophage colony-stimulating factor (rhuGM-CSF) has proved to accelerate bone marrow recovery after cytostatic chemotherapy, we studied its effects on hematopoietic regenera...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Link H,Boogaerts MA,Carella AM,Ferrant A,Gadner H,Gorin NC,Harabacz I,Harousseau JL,Hervé P,Holldack J

    更新日期:1992-11-01 00:00:00

  • High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy.

    abstract::Seventy-five patients with resistant acute leukemia or lymphoma received high-dose cyclophosphamide and etoposide to explore the activity of this combination in resistant hematologic malignancies, and to determine the maximum doses of these drugs that can be combined without bone marrow transplantation. Etoposide was ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Brown RA,Herzig RH,Wolff SN,Frei-Lahr D,Pineiro L,Bolwell BJ,Lowder JN,Harden EA,Hande KR,Herzig GP

    更新日期:1990-08-01 00:00:00

  • Suppression of mouse myelopoiesis by administration of human lactoferrin in vivo and the comparative action of human transferrin.

    abstract::Purified human lactoferrin was assessed for its influence in vivo in untreated mice and in mice undergoing rebound myelopoiesis after sublethal dosages of Cytoxan. Fully iron-saturated lactoferrin suppressed the numbers of granulocytes and monocytes per femur, the numbers of granulocyte-macrophage progenitor cells (CF...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gentile P,Broxmeyer HE

    更新日期:1983-05-01 00:00:00

  • Vascular endothelial growth factor-A induces plaque expansion in ApoE knock-out mice by promoting de novo leukocyte recruitment.

    abstract::Vascular endothelial growth factor-A is widely used in clinical trials for the treatment of cardiac ischemia. VEGF-A was recently suggested to act in a proinflammatory manner, which could aggravate adjacent atherogenesis in VEGF-A-based therapy. To assess potential bystander effects, VEGF-A was focally overexpressed i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-07-031773

    authors: Lucerna M,Zernecke A,de Nooijer R,de Jager SC,Bot I,van der Lans C,Kholova I,Liehn EA,van Berkel TJ,Yla-Herttuala S,Weber C,Biessen EA

    更新日期:2007-01-01 00:00:00

  • EZH2 mutational status predicts poor survival in myelofibrosis.

    abstract::We genotyped 370 subjects with primary myelofibrosis (PMF) and 148 with postpolycythemia vera/postessential thrombocythemia (PPV/PET) MF for mutations of EZH2. Mutational status at diagnosis was correlated with hematologic parameters, clinical manifestations, and outcome. A total of 25 different EZH2 mutations were de...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-363424

    authors: Guglielmelli P,Biamonte F,Score J,Hidalgo-Curtis C,Cervantes F,Maffioli M,Fanelli T,Ernst T,Winkelman N,Jones AV,Zoi K,Reiter A,Duncombe A,Villani L,Bosi A,Barosi G,Cross NC,Vannucchi AM

    更新日期:2011-11-10 00:00:00

  • Thrombin induces the expression of oncostatin M via AP-1 activation in human macrophages: a link between coagulation and inflammation.

    abstract::Macrophages as inflammatory cells are involved in the pathogenesis of atherosclerosis that today is recognized as an inflammatory disease. Activation of coagulation leads to the late complication of atherosclerosis, namely atherothrombosis with its clinical manifestations stroke, unstable angina, myocardial infarction...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-01-200915

    authors: Kastl SP,Speidl WS,Katsaros KM,Kaun C,Rega G,Assadian A,Hagmueller GW,Hoeth M,de Martin R,Ma Y,Maurer G,Huber K,Wojta J

    更新日期:2009-09-24 00:00:00

  • Ikaros limits basophil development by suppressing C/EBP-α expression.

    abstract::The Ikaros gene (Ikzf1) encodes a family of zinc-finger transcription factors implicated in hematopoietic cell differentiation. Here we show that Ikaros suppresses the development of basophils, which are proinflammatory cells of the myeloid lineage. In the absence of extrinsic basophil-inducing signals, Ikaros(-/-) (I...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-04-494625

    authors: Rao KN,Smuda C,Gregory GD,Min B,Brown MA

    更新日期:2013-10-10 00:00:00

  • Pediatric acute lymphoblastic leukemia: where are we going and how do we get there?

    abstract::Improved supportive care, more precise risk stratification, and personalized chemotherapy based on the characteristics of leukemic cells and hosts (eg, pharmacokinetics and pharmacogenetics) have pushed the cure rate of childhood acute lymphoblastic leukemia to near 90%. Further increase in cure rate can be expected f...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-05-378943

    authors: Pui CH,Mullighan CG,Evans WE,Relling MV

    更新日期:2012-08-09 00:00:00

  • Mapping of genes that control the antibody response to human factor IX in mice.

    abstract::We tested the hypothesis that the antibody response to human factor IX in mice is controlled by genetic factors, especially histocompatibility antigens. Seven inbred mouse strains were immunized against human factor IX by adenoviral gene transfer or serial injections of human factor IX protein. A/J mice had the highes...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-1126

    authors: Lozier JN,Tayebi N,Zhang P

    更新日期:2005-02-01 00:00:00

  • The VEGF-regulated transcription factor HLX controls the expression of guidance cues and negatively regulates sprouting of endothelial cells.

    abstract::The HLX gene encoding a diverged homeobox transcription factor has been found to be up-regulated by vascular endothelial growth factor-A (VEGF-A) in endothelial cells. We have now investigated the gene repertoire induced by HLX and its potential biologic function. HLX strongly increased the transcripts for several rep...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-07-293209

    authors: Testori J,Schweighofer B,Helfrich I,Sturtzel C,Lipnik K,Gesierich S,Nasarre P,Hofer-Warbinek R,Bilban M,Augustin HG,Hofer E

    更新日期:2011-03-03 00:00:00

  • Development of functional human blood and immune systems in NOD/SCID/IL2 receptor {gamma} chain(null) mice.

    abstract::Here we report that a new nonobese diabetic/severe combined immunodeficient (NOD/SCID) mouse line harboring a complete null mutation of the common cytokine receptor gamma chain (NOD/SCID/interleukin 2 receptor [IL2r] gamma(null)) efficiently supports development of functional human hemato-lymphopoiesis. Purified human...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-02-0516

    authors: Ishikawa F,Yasukawa M,Lyons B,Yoshida S,Miyamoto T,Yoshimoto G,Watanabe T,Akashi K,Shultz LD,Harada M

    更新日期:2005-09-01 00:00:00

  • Randomized phase 2 study of low-dose decitabine vs low-dose azacitidine in lower-risk MDS and MDS/MPN.

    abstract::Hypomethylating agents (HMAs) improve survival in patients with higher-risk myelodysplastic syndromes (MDS) but are less well-studied in lower-risk disease. We compared the safety and efficacy of low-dose decitabine vs low-dose azacitidine in this group of patients. Adults with low- or intermediate 1-risk MDS or MDS/m...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2017-06-788497

    authors: Jabbour E,Short NJ,Montalban-Bravo G,Huang X,Bueso-Ramos C,Qiao W,Yang H,Zhao C,Kadia T,Borthakur G,Pemmaraju N,Sasaki K,Estrov Z,Cortes J,Ravandi F,Alvarado Y,Komrokji R,Sekeres MA,Steensma DP,DeZern A,Roboz G,

    更新日期:2017-09-28 00:00:00

  • Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children's Leukemia Group phase 3 trial.

    abstract::Asparaginase is an enzyme used in the treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma in children. It has minimal bone marrow toxicity. Its major side effects are anaphylaxis, pancreatitis, diabetes, coagulation abnormalities, and thrombosis, especially intracranial. It is derived from 2 different...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1182/blood.v99.8.2734

    authors: Duval M,Suciu S,Ferster A,Rialland X,Nelken B,Lutz P,Benoit Y,Robert A,Manel AM,Vilmer E,Otten J,Philippe N

    更新日期:2002-04-15 00:00:00

  • Mammalian homeobox B6 expression can be correlated with erythropoietin production sites and erythropoiesis during development, but not with hematopoietic or nonhematopoietic stem cell populations.

    abstract::There has been increasing interest in the involvement of mammalian homeobox (HOX) genes in hematopoietic regulation. The HOX genes are clustered in 4 chromosomes in mice and humans. In general, 5' end HOX gene expression is predominant in hematopoietic stem cell populations, whereas 3' end HOX gene expression are prim...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zimmermann F,Rich IN

    更新日期:1997-04-15 00:00:00

  • Prostaglandin E(2) regulates murine hematopoietic stem/progenitor cells directly via EP4 receptor and indirectly through mesenchymal progenitor cells.

    abstract::Prostaglandin E(2) (PGE(2)) regulates hematopoietic stem/progenitor cell (HSPC) activity. However, the receptor(s) responsible for PGE(2) signaling remains unclear. Here, we identified EP4 as a receptor activated by PGE(2) to regulate HSPCs. Knockdown of Ep4 in HSPCs reduced long-term reconstitution capacity, whereas ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-06-437889

    authors: Ikushima YM,Arai F,Hosokawa K,Toyama H,Takubo K,Furuyashiki T,Narumiya S,Suda T

    更新日期:2013-03-14 00:00:00

  • Autologous and MHC class I-negative allogeneic tumor cells secreting IL-12 together cure disseminated A20 lymphoma.

    abstract::Cytokine gene-modified tumor cells have increased immunogenicity and retain the antigenic repertoire of a particular neoplasia. However, practical concerns have led to an increased interest in allogeneic gene-transduced bystander cells as a broader source of cytokines for autologous tumor cell-based vaccines. Here, we...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-03-0991

    authors: Curti A,Parenza M,Colombo MP

    更新日期:2003-01-15 00:00:00

  • Regulatory effects of stem cell factor and interleukin-4 on adhesion of human mast cells to extracellular matrix proteins.

    abstract::Mast cells are inflammatory and immunoregulatory cells resident in tissues. They develop from bone marrow-derived progenitor cells that enter the tissue through the blood circulation. The specific localization and migration of mast cells in tissues is dependent on their interaction with extracellular matrix (ECM) prot...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.3.966

    authors: Lorentz A,Schuppan D,Gebert A,Manns MP,Bischoff SC

    更新日期:2002-02-01 00:00:00

  • Role of calcium in glucocorticosteroid-induced apoptosis of thymocytes and lymphoma cells: resurrection of old theories by new findings.

    abstract::Since the initial observations by Kaiser and Edelman, interest in the role of calcium in ACS-induced apoptosis has wavered, in part because of the fact that extracellular calcium is only necessary for induction of apoptosis in thymocytes, but not in peripheral lymphocytes or lymphoma cells. Now, as result of molecular...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:

    authors: Distelhorst CW,Dubyak G

    更新日期:1998-02-01 00:00:00

  • Enhanced production of nitric oxide by bone marrow cells and increased sensitivity to macrophage colony-stimulating factor (CSF) and granulocyte-macrophage CSF after benzene treatment of mice.

    abstract::Nitric oxide is a short-lived reactive mediator that inhibits bone marrow (BM) cell proliferation induced by granulocyte-macrophage colony-stimulating factor (GM-CSF). The present studies show that nitric oxide also inhibits macrophage colony-stimulating factor (M-CSF)-induced growth of mouse BM cells, an effect that ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Punjabi CJ,Laskin JD,Hwang SM,MacEachern L,Laskin DL

    更新日期:1994-06-01 00:00:00

  • Shiga-like toxin purges human lymphoma from bone marrow of severe combined immunodeficient mice.

    abstract::Shiga-like toxin-1 (SLT-1) is a bacterial toxin that kills cells by inhibiting protein synthesis. SLT-1 is composed of one cytotoxic A-subunit and five B-subunits that bind to CD77, a cell-surface glycolipid. In the human hematopoietic system, CD77 expression is restricted to a subset of activated B cells and derived ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: LaCasse EC,Saleh MT,Patterson B,Minden MD,Gariépy J

    更新日期:1996-09-01 00:00:00

  • RUNX1 regulates corepressor interactions of PU.1.

    abstract::The transcription factor (TF) RUNX1 cooperates with lineage-specifying TFs (eg, PU.1/SPI1) to activate myeloid differentiation genes, such as macrophage and granulocyte macrophage colony-stimulating factor receptors (MCSFR and GMCSFR). Disruption of cooperative gene activation could contribute to aberrant repression o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-10-312512

    authors: Hu Z,Gu X,Baraoidan K,Ibanez V,Sharma A,Kadkol S,Munker R,Ackerman S,Nucifora G,Saunthararajah Y

    更新日期:2011-06-16 00:00:00

  • Naive recirculating B cells mature simultaneously in the spleen and bone marrow.

    abstract::We have recently demonstrated that IgD(hi) B cells can occupy an extravascular perisinusoidal niche in the bone marrow in addition to the well-established follicular niche in conventional secondary lymphoid organs. The spleen has long been considered to be the site at which newly formed B lymphocytes mature into IgD(h...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-021089

    authors: Cariappa A,Chase C,Liu H,Russell P,Pillai S

    更新日期:2007-03-15 00:00:00

  • Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation following failure of imatinib mesylate therapy.

    abstract::Chronic myeloid leukemia (CML) with T315I mutation has been reported to have poor prognosis. We analyzed 27 patients with T315I, including 20 who developed T315I after imatinib failure (representing 11% of 186 patients with imatinib failure), and 7 of 23 who developed new mutations after second tyrosine kinase inhibit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-11-123950

    authors: Jabbour E,Kantarjian H,Jones D,Breeden M,Garcia-Manero G,O'Brien S,Ravandi F,Borthakur G,Cortes J

    更新日期:2008-07-01 00:00:00

  • There's no such fool like an immunosenescent fool.

    abstract::In this issue of Blood, Stepensky et al provide an astute description of immunosenescence arising from deficiency in tripeptidyl peptidase II (TPPII). Senescence of T and B lymphocytes is a striking finding, which has recently come into the limelight because it can be linked to primary immunodeficiency syndromes with ...

    journal_title:Blood

    pub_type: 评论,杂志文章

    doi:10.1182/blood-2014-12-614149

    authors: Seidel MG

    更新日期:2015-01-29 00:00:00